Tryptamine to Plug $6M Placement Funding Into Acceleration of IV-infused Psilocybin Treatment Trials

The Market HeraldOct 29 19:59 ET

Tryptamine Therapeutics A$6 Million Placement Cornerstoned by Merchant Biotech Fund and Dr Daniel Tillett | ASX:TYP, OTC:TYPTF

Proactive InvestorsOct 29 19:49 ET

Tryptamine Therapeutics Plans Capital Raising Amid Trading Halt

TipRanksOct 27 22:37 ET

Just the Facts: Tryptamine Therapeutics' TRP-8803 Clears Phase 1b Safety Trial | ASX:TYP, OTC:TYPTF

Proactive InvestorsOct 18 08:17 ET

Tryptamine Therapeutics Psilocybin Asset TRP-8803 Clears Safety Test Following Phase 1b Trial

Investing.com Oct 17 19:21 ET

Tryptamine Therapeutics Ltd: Annual Report to shareholders

ASXSep 30 04:21 ET · Announcements